137 related articles for article (PubMed ID: 10323278)
1. Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries.
De la Lande IS; Stafford I; Horowitz JD
Eur J Pharmacol; 1999 Apr; 370(1):39-46. PubMed ID: 10323278
[TBL] [Abstract][Full Text] [Related]
2. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
Li PL; Jin MW; Campbell WB
Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
[TBL] [Abstract][Full Text] [Related]
4. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
5. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
Miller MR; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ; Megson IL
Eur J Pharmacol; 2000 Nov; 408(3):335-43. PubMed ID: 11090652
[TBL] [Abstract][Full Text] [Related]
6. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
7. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
Miller MR; Megson IL; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ
Eur J Pharmacol; 2000 Sep; 403(1-2):111-9. PubMed ID: 10969151
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
Henry PJ; Drummer OH; Horowitz JD
Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
[TBL] [Abstract][Full Text] [Related]
9. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
10. Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate.
Sarr M; Lobysheva I; Diallo AS; Stoclet JC; Schini-Kerth VB; Muller B
Eur J Pharmacol; 2005 Apr; 513(1-2):119-23. PubMed ID: 15878716
[TBL] [Abstract][Full Text] [Related]
11. Nitric-oxide-guanylyl-cyclase-dependent and -independent components of multiple forms of long-term synaptic depression.
Gage AT; Reyes M; Stanton PK
Hippocampus; 1997; 7(3):286-95. PubMed ID: 9228526
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery.
Zhang CL; De la Lande IS; Stafford I; Horowitz JD
Eur J Pharmacol; 1994 Feb; 252(3):299-304. PubMed ID: 8162952
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate relaxes the isolated bovine ophthalmic artery: involvement of phosphoinositide 3-kinase-Akt-nitric oxide/cGMP signalling pathway.
Romano MR; Lograno MD
Eur J Pharmacol; 2009 Apr; 608(1-3):48-53. PubMed ID: 19249297
[TBL] [Abstract][Full Text] [Related]
14. Involvement of guanylyl cyclase, protein kinase A and Na+ K+ ATPase in relaxations of bovine isolated bronchioles induced by GEA 3175, an NO donor.
Elmedal Laursen B; Mulvany MJ; Simonsen U
Pulm Pharmacol Ther; 2006; 19(3):179-88. PubMed ID: 16023394
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
16. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries.
Mingone CJ; Gupte SA; Iesaki T; Wolin MS
Am J Physiol Lung Cell Mol Physiol; 2003 Aug; 285(2):L296-304. PubMed ID: 12691956
[TBL] [Abstract][Full Text] [Related]
18. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of glyceryl trinitrate response in isolated bovine coronary arteries.
De la Lande IS; Stafford I; Horowitz JD
Eur J Pharmacol; 1996 Dec; 318(1):65-71. PubMed ID: 9007514
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
